Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025)
Corvus Pharmaceuticals' (CRVS) quarterly Other Non-Current Liabilities came in at $3.8 million in Q1 2025, down 86.86% quarter-over-quarter from $28.9 million in Q4 2024.
Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
Corvus Pharmaceuticals' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $3.8 million in Q1 2025; TTM through Mar 2025 was $3.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $28.9 million, changed N/A from the prior year.
- Other Non-Current Liabilities declined to $3.8 million in Q1 2025 per CRVS's latest filing, from $28.9 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $40.0 million in Q3 2024 and bottomed at $3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 28.91 Mn |
| Sep 30, 2024 | 39.96 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Dec 31, 2018 | 869,000.00 |
| Sep 30, 2018 | 627,000.00 |
| Jun 30, 2018 | 741,000.00 |
| Mar 31, 2018 | 857,000.00 |
| Dec 31, 2017 | 971,000.00 |
| Sep 30, 2017 | 1.08 Mn |
| Jun 30, 2017 | 1.19 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 1.41 Mn |
| Sep 30, 2016 | 1.26 Mn |
| Jun 30, 2016 | 1.35 Mn |
| Mar 31, 2016 | 1.29 Mn |
| Dec 31, 2015 | 710,000.00 |